Insider Trading › PTHS › Insiders

Pelthos Therapeutics Inc.

PTHS·NYSE·United States United States·Insider activity
$21.48
+0.98 (+4.78%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
PTHS
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
PTHSS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

In the last 180 days, PTHS insiders filed 2 purchases ($1.0M) and 12 sales ($149K) on the open market, by 5 insiders. Newest filing Oct 6, 2026 (yesterday).

Net Insider Buying by Quarter

Shares bought (+) or sold (−) on the open market by PTHS insiders · Form 4 · last two years
-50.0K-25.0K025.0K50.0K2025 Q1: 02025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: -10.0K2025 Q42026 Q1: 02026 Q12026 Q2: 31.4K2026 Q22026 Q3: -2,1412026 Q32026 Q4: -2,1412026 Q4

On Record

$1.0MPurchases · 180 days
$149KSales · 180 days
26Open-market transactions on record
5Insiders filing · 180 days

Purchases (code P) and sales (code S) of PTHS common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).

Insider Transactions

26 on record · newest trade first
AllPurchasesSalesOfficers & directors
InsiderTypeSharesPriceValueHeld afterTradedFiled
Greenleaf PeterDirector · Director Sale −797 $21.17 $17K23.1Kdirect Oct 2, 2026Oct 6, 2026 Form 4 ↗
Friedberg Ezra MDirector · Director Sale −558 $20.72 $12K80.5Kdirect Oct 2, 2026Oct 6, 2026 Form 4 ↗
Pauls MatthewDirector · Director Sale −786 $21.00 $17K13.6Kdirect Oct 2, 2026Oct 6, 2026 Form 4 ↗
Friedberg Ezra MDirector · Director Sale −534 $26.03 $14K81.1Kdirect Jul 2, 2026Jul 7, 2026 Form 4 ↗
Friedberg Ezra MDirector · Director Sale −24 $27.33 $65681.0Kdirect Jul 2, 2026Jul 7, 2026 Form 4 ↗
Pauls MatthewDirector · Director Sale −94 $27.36 $3K14.4Kdirect Jul 2, 2026Jul 7, 2026 Form 4 ↗
Pauls MatthewDirector · Director Sale −692 $26.00 $18K14.5Kdirect Jul 2, 2026Jul 7, 2026 Form 4 ↗
Greenleaf PeterDirector · Director Sale −85 $27.27 $2K23.9Kdirect Jul 2, 2026Jul 7, 2026 Form 4 ↗
Greenleaf PeterDirector · Director Sale −712 $26.00 $19K24.0Kdirect Jul 2, 2026Jul 7, 2026 Form 4 ↗
Friedberg Ezra MDirector Sale −59 $27.94 $2K81.6Kdirect Jun 15, 2026Jun 17, 2026 Form 4 ↗
Friedberg Ezra MDirector Sale −224 $27.12 $6K81.7Kdirect Jun 15, 2026Jun 17, 2026 Form 4 ↗
Davis Todd CDirector Purchase +503 $28.73 $14K75.8Kdirect Jun 11, 2026Jun 15, 2026 Form 4 ↗
Davis Todd CDirector Purchase +35.4K $27.80 $985K75.3Kdirect Jun 11, 2026Jun 15, 2026 Form 4 ↗
Francis Knuettel IICFO, Treas & Secty Sale −1,500 $26.84 $40K11.3Kindirect May 22, 2026May 26, 2026 Form 4 ↗
Malamut RichardDirector Sale −280 $21.36 $6K27.4Kdirect Apr 2, 2026Apr 6, 2026 Form 4 ↗
Malamut RichardDirector Sale −310 $20.51 $6K27.7Kdirect Apr 2, 2026Apr 6, 2026 Form 4 ↗
Friedberg Ezra MDirector Sale −265 $21.36 $6K82.0Kdirect Apr 2, 2026Apr 6, 2026 Form 4 ↗
Friedberg Ezra MDirector Sale −293 $20.51 $6K82.3Kdirect Apr 2, 2026Apr 6, 2026 Form 4 ↗
Pauls MatthewDirector Sale −371 $21.36 $8K15.2Kdirect Apr 2, 2026Apr 6, 2026 Form 4 ↗
Pauls MatthewDirector Sale −415 $20.52 $9K15.5Kdirect Apr 2, 2026Apr 6, 2026 Form 4 ↗
Greenleaf PeterDirector Sale −377 $21.36 $8K24.7Kdirect Apr 2, 2026Apr 6, 2026 Form 4 ↗
Greenleaf PeterDirector Sale −420 $20.52 $9K25.1Kdirect Apr 2, 2026Apr 6, 2026 Form 4 ↗
Friedberg Ezra MDirector Sale −2,000 $28.01 $56K30.0Kindirect Nov 25, 2025Nov 26, 2025 Form 4 ↗
Friedberg Ezra MDirector Sale −1 $28.50 $2932.0Kindirect Nov 25, 2025Nov 26, 2025 Form 4 ↗
Friedberg Ezra MDirector Sale −2,000 $28.14 $56K32.0Kindirect Nov 25, 2025Nov 26, 2025 Form 4 ↗
Friedberg Ezra MDirector Sale −5,999 $28.00 $168K34.0Kindirect Nov 25, 2025Nov 26, 2025 Form 4 ↗

Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →